Back to dashboard
All PlansAdministrativeMedium impact

Prescribing Tips: Triple Inhaled Therapy

EmblemHealth·Pulmonology, Family Medicine, Internal Medicine +1 more·Provider News
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

Providers must now check that patients prescribed triple inhaled therapy are not also prescribed duplicate LABA or LAMA medications. A reference chart is available to identify duplicate therapies that should be avoided, and clinical pharmacist support is available for finding appropriate alternatives.

Action Required

Action needed
Immediately: Providers must check all triple inhaled therapy prescriptions to ensure patients are not also prescribed duplicate long-acting beta2-adrenergic (LABA) or long-acting muscarinic antagonist (LAMA) medications. Download and reference the 'Simplify Treatment for Patients on Triple Inhaled Therapy' chart from the policy source. Contact clinical pharmacist at 929-988-1834 for assistance with alternative medications when duplicates are identified.

Related policy hubs